Leveraging Genetic Evidence to Prioritise Drug Targets at the Gene and Pathway Level
Priority index or Pi is developed as a genomic-led target prioritisation system. It integrates functional genomic predictors, knowledge of network connectivity and immune ontologies to prioritise potential drug targets at the gene and pathway level.
